The first Bio-Techne trade was made in Q1 2021. Since then Sands Capital bought shares nine more times and sold shares on four occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Bio-Techne anymore.
Highlighted on July 10, it was unveiled in an SEC filing that Higgins, Director at Bio-Techne (NASDAQ: TECH ), executed a significant transaction involving t...
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be down...
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the sa...
… of Bio-Techne Co. (NASDAQ: TECH – Get Rating) by 305.6% … . Analysts Set New Price Targets TECH has been the subject of … 4.04. Bio-Techne (NASDAQ: TECH – ...